This protocol is judged by an institutional evaluation board, an independent team that evaluations any medical trials involving human beings. If a study includes a Schedule I drug, once the board approves the protocol as ethical, the scientists really need to apply for an investigational new drug (IND) variety within the FDA.“It’s important to